We are live on ! Find out more
Jeff Yass

Jeff Yass Susquehanna International Group

AUM $1.26T Turnover 23.45%
1-Year Est. Return 41.03%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+1.48%
1 Year Est. Return
+41.03%
3 Year Est. Return
+173.37%
5 Year Est. Return
+166.23%
10 Year Est. Return
+509.07%
AUM
$1.26T
AUM Growth
-$27.4B
Cap. Flow
-$3.98B
Cap. Flow %
-0.32%
Top 10 Hldgs %
26.48%
Holding
15,103
New
1,828
Increased
5,364
Reduced
6,090
Closed
1,713
Avg Time Held Equity + Options
3.9 years
Top 10 Avg Time Held Equity + Options
4.7 years
Top 20 Avg Time Held Equity + Options
5.5 years
Avg Time Held Equity only
2.2 years
Top 10 Avg Time Held Equity only
1.6 years
Top 20 Avg Time Held Equity only
3.6 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 94.76%
2 Technology 2.14%
3 Communication Services 0.56%
4 Consumer Discretionary 0.56%
5 Healthcare 0.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MMLP icon
13101
Martin Midstream Partners
MMLP
$82.6M
$22.5K ﹤0.01%
10,134
-676
-6% -$1.57K
2022 Q3
16 quarters
LVWR icon
13102
PUT
LiveWire
LVWR
$76M
$22.5K ﹤0.01%
+14,700
New +$18.2K
2026 Q3
0 quarters
ALXO icon
13103
CALL
ALX Oncology
ALXO
$134M
$22.4K ﹤0.01%
16,100
-8,700
-35% -$16.8K
2025 Q3
4 quarters
TDACW icon
13104
Translational Development Acquisition Corp Warrants
TDACW
$6.04M
$22.3K ﹤0.01%
+15,363
New +$26.6K
2026 Q3
0 quarters
MBOT icon
13105
PUT
Microbot Medical
MBOT
$48.5M
$22.1K ﹤0.01%
18,400
-107,300
-85% -$173K
2025 Q1
6 quarters
TLPH icon
13106
PUT
Talphera
TLPH
$41.6M
$21.7K ﹤0.01%
+18,700
New +$23.5K
2026 Q3
0 quarters
PULM icon
13107
Pulmatrix
PULM
$4.89M
$21.7K ﹤0.01%
+14,252
New +$22.8K
2026 Q3
0 quarters
ONCO icon
13108
Onconetix
ONCO
$2.11M
$21.7K ﹤0.01%
+2,769
New +$22.6K
2026 Q3
0 quarters
MBOT icon
13109
CALL
Microbot Medical
MBOT
$48.5M
$21.1K ﹤0.01%
17,600
-67,700
-79% -$109K
2026 Q1
2 quarters
YTRA icon
13110
Yatra Online
YTRA
$56M
$21K ﹤0.01%
22,288
+3,146
+16% +$2.96K
2026 Q1
2 quarters
GIGM icon
13111
GigaMedia
GIGM
$15.7M
$21K ﹤0.01%
15,522
+1,780
+13% +$2.51K
2025 Q3
4 quarters
DAVA icon
13112
CALL
Endava
DAVA
$67.1M
$20.9K ﹤0.01%
11,700
-62,400
-84% -$177K
2023 Q3
12 quarters
DFDVW icon
13113
DeFi Development Warrant
DFDVW
$702K
$20.8K ﹤0.01%
24,505
-14,698
-37% -$7.88K
2025 Q4
3 quarters
SPWH icon
13114
Sportsman's Warehouse
SPWH
$48.5M
$20.8K ﹤0.01%
+18,388
New +$21.9K
2026 Q3
0 quarters
CLVT icon
13115
PUT
Clarivate
CLVT
$1.38B
$20.7K ﹤0.01%
12,400
+2,200
+22% +$4.49K
2026 Q1
2 quarters
PROK icon
13116
PUT
ProKidney
PROK
$217M
$20.6K ﹤0.01%
+12,400
New +$20.9K
2026 Q3
0 quarters
ORKT icon
13117
Orangekloud Technology
ORKT
$5.35M
$20.4K ﹤0.01%
+20,612
New +$21K
2026 Q3
0 quarters
GMM icon
13118
Global Mofy AI
GMM
$19.8M
$20.4K ﹤0.01%
+11,328
New +$28.7K
2026 Q3
0 quarters
ALEC icon
13119
Alector
ALEC
$383M
$20.3K ﹤0.01%
10,999
-13,124
-54% -$25.3K
2020 Q1
26 quarters
RKTO icon
13120
Rocket One
RKTO
$7.53M
$20.3K ﹤0.01%
28,436
+2,470
+10% +$1.92K
2026 Q2
1 quarter
KMRK icon
13121
K-Tech Solutions
KMRK
$27.6M
$20.3K ﹤0.01%
+17,207
New +$18.6K
2026 Q3
0 quarters
NBP icon
13122
NovaBridge Biosciences American Depositary Shares
NBP
$104M
$20.3K ﹤0.01%
14,839
-13,700
-48% -$24.1K
2025 Q2
5 quarters
JF icon
13123
J and Friends Holdings
JF
$17M
$20.2K ﹤0.01%
21,970
+1,306
+6% +$1.24K
2026 Q2
1 quarter
LITS icon
13124
CALL
Lite Strategy
LITS
$24.1M
$20.1K ﹤0.01%
15,200
-6,200
-29% -$6.41K
2026 Q1
2 quarters
AIV icon
13125
PUT
Aimco
AIV
$204M
$20K ﹤0.01%
10,100
– –
2025 Q2
5 quarters

Similar funds

Jeff Yass's Q3 2026 Portfolio in Review

As of Q3 2026, Jeff Yass held 15,103 positions worth $1.26T, down 2.1% from $1.28T the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Jeff Yass's Q3 2026 filing shows 1,828 new, 5,364 increased, 6,090 reduced and 1,713 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 4,178,565 shares worth $405M. The largest sale was Microsoft, an estimated $2.88B.

By sector, the portfolio is most concentrated in Miscellaneous at 95% of assets, up from 94% a quarter earlier, followed by Technology and Communication Services.

  • Jeff Yass's largest Q3 2026 buy was iShares Core MSCI EAFE ETF: 4,178,565 shares worth $405M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2026, an estimated $4.73B increase.
  • Jeff Yass's biggest Q3 2026 reduction was Microsoft, cutting an estimated $2.88B.
  • Jeff Yass fully exited Capital Group Growth ETF in Q3 2026, selling an estimated $279M.
  • Jeff Yass's ten largest holdings make up 26% of its $1.26T portfolio in Q3 2026.
  • Jeff Yass opened 1,828 new positions and closed 1,713 in Q3 2026.
  • Jeff Yass's portfolio value fell 2.1% quarter-over-quarter to $1.26T.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.